Loading…
Abrdn Healthcare Investors is projected to rise to $26.64 by 2027, a +37% move from its current price of $19.45. HQH is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean neutral.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $19.26 | $19.46 | $19.66 | +0.03% |
| May 30 | $19.18 | $19.46 | $19.75 | +0.06% |
| May 31 | $19.12 | $19.47 | $19.82 | +0.09% |
| Jun 1 | $19.08 | $19.47 | $19.88 | +0.12% |
| Jun 2 | $19.04 | $19.48 | $19.93 | +0.15% |
| Jun 3 | $19.00 | $19.48 | $19.98 | +0.18% |
| Jun 4 | $18.97 | $19.49 | $20.03 | +0.21% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $18.97 | $19.49 | $20.03 | +0.21% |
| Week 2 | $18.80 | $19.53 | $20.30 | +0.42% |
| Week 3 | $18.67 | $19.57 | $20.52 | +0.63% |
| Week 4 | $18.58 | $19.61 | $20.71 | +0.84% |
| Week 5 | $18.50 | $19.65 | $20.89 | +1.05% |
| Week 6 | $18.43 | $19.70 | $21.05 | +1.27% |
| Week 7 | $18.37 | $19.74 | $21.21 | +1.48% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe and seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies and uses fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or secure outside sources of capital to create its portfolio.
Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
HQH is the Abrdn Healthcare Investors fund, trading at $19.47 with a market cap of $1.11B and a rank of 2456. The fund’s current price and market position are noted within a broad global healthcare equity context.
A major floor 11.3% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.9% away) — a key level to hold.
The nearest ceiling, 4.6% above — a clean break opens room to run.
A major ceiling 6.7% above — clearing it would confirm fresh momentum.
Key HQH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of HQH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $19.57 | Sell | $19.54 | Sell |
| MA 10 | $19.76 | Sell | $19.67 | Sell |
| MA 20 | $19.86 | Sell | $19.70 | Sell |
| MA 50 | $19.18 | Buy | $19.44 | Buy |
| MA 100 | $19.16 | Buy | $19.15 | Buy |
| MA 200 | $18.63 | Buy | $18.63 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.11 | Neutral |
| Stoch RSI (14) | 9.20 | Buy |
| CCI (20) | -111.04 | Sell |
| Williams %R (14) | -90.82 | Info |
| MACD (12,26,9) | -0.12 | Sell |
| ROC (12) | -2.94 | Sell |
| Bollinger %B (20,2) | 0.15 | Neutral |
| Stochastic %K (14) | 9.18 | Buy |
| TRIX (15) | 0.13 | Buy |
| Awesome (5,34) | -0.15 | Sell |
| Ultimate (7,14,28) | 35.56 | Neutral |
| Momentum (10) | -0.89 | Sell |
| Aroon Osc (25) | 48.00 | Buy |
| Hull MA (9) | 19.35 | Buy |
| ADX (14) | 15.55 | Neutral |
| ATR (14) | 0.19 | Info |
The 30-day technical picture is bullish. RSI(14) is 50, with a SMA50 of $19.13 and a SMA200 of $18.60. Near-term support sits at $19.27 and resistance at $20.34. The 30-day price range runs from $18.13 to $20.91 as momentum ebbs and flows.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $17.25 | $19.45 | $25.68 | 0% | Neutral | |
| $21.77 | $26.64 | $34.14 | +37% | Bullish | |
| $25.62 | $31.94 | $41.99 | +64% | Bullish | |
| $27.23 | $34.45 | $46.23 | +77% | Bullish | |
| $29.91 | $38.35 | $52.38 | +97% | Bullish | |
| $30.36 | $39.40 | $54.65 | +103% | Bullish | |
| $32.78 | $43.01 | $60.50 | +121% | Bullish | |
| $38.58 | $51.16 | $72.89 | +163% | Bullish | |
| $42.16 | $56.45 | $81.37 | +190% | Bullish | |
| $47.78 | $64.58 | $94.12 | +232% | Bullish | |
| $64.43 | $90.81 | $138.66 | +367% | Bullish | |
| $118.15 | $178.57 | $292.19 | +818% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $17.25 | $19.45 | $22.86 | +0.00% |
| June 2026 | $17.24 | $20.11 | $23.92 | +3.40% |
| July 2026 | $17.04 | $19.99 | $23.99 | -0.61% |
| August 2026 | $17.01 | $20.05 | $24.24 | +0.28% |
| September 2026 | $17.47 | $20.67 | $25.14 | +3.10% |
| October 2026 | $17.51 | $20.78 | $25.42 | +0.57% |
| November 2026 | $17.16 | $20.42 | $25.09 | -1.73% |
| December 2026 | $17.43 | $20.81 | $25.68 | +1.89% |
Click any year to see its month-by-month HQH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The HQH price prediction for 2026 points to an average of $19.45 (low $17.25, high $25.68) — a potential gain of 0% on today's $19.45. Price action looks broadly range-bound.
In 2027, HQH is projected to trade between $21.77 and $34.14, averaging $26.64 — a potential gain of +37% from today's $19.45. That is up +37% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Abrdn Healthcare Investors's 2028 outlook centres on $31.94, within a $25.62 to $41.99 range. That is up +20% on the projected 2027 average. That marks a +64% change versus current levels. Momentum favours further upside here.
By 2029, HQH could reach as high as $46.23, with a base case around $34.45 and support toward $27.23 — roughly +77% from $19.45. Buyers look set to stay in control over this stretch.
Expect HQH to range from $29.91 to $52.38 through 2030. The $38.35 average target implies a +97% move from current prices. That is up +11% on the projected 2029 average. Momentum favours further upside here.
The HQH price prediction for 2031 points to an average of $39.40 (low $30.36, high $54.65) — a potential gain of +103% on today's $19.45. Buyers look set to stay in control over this stretch.
In 2032, HQH is projected to trade between $32.78 and $60.50, averaging $43.01 — a potential gain of +121% from today's $19.45. That is up +9% on the projected 2031 average. Momentum favours further upside here.
Abrdn Healthcare Investors's 2033 outlook centres on $51.16, within a $38.58 to $72.89 range. That is up +19% on the projected 2032 average. That marks a +163% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, HQH could reach as high as $81.37, with a base case around $56.45 and support toward $42.16 — roughly +190% from $19.45. Momentum favours further upside here.
Expect HQH to range from $47.78 to $94.12 through 2035. The $64.58 average target implies a +232% move from current prices. That is up +14% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The HQH price prediction for 2040 points to an average of $90.81 (low $64.43, high $138.66) — a potential gain of +367% on today's $19.45. Momentum favours further upside here.
In 2050, HQH is projected to trade between $118.15 and $292.19, averaging $178.57 — a potential gain of +818% from today's $19.45. That is up +97% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in HQH today (≈ 51.413882 HQH) could be worth
$9,180.9
+$8,180.9 (+818%) by 2050 · US Dollar
Based on the average projected HQH price of $178.57 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in HQHwould be worth at today's price.
$1,000 invested in HQH on May 27, 2025 (≈ 64.935067 HQH) would be worth
$1,262.99
+$262.99 (+26.3%) today · 1.26× · US Dollar
Based on a HQH entry price of $15.4 vs. today's $19.45.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $20 | $972.5 | -2.8% |
| 1 month ago | $19.61 | $991.84 | -0.8% |
| 3 months ago | $19.05 | $1,021 | +2.1% |
| 6 months ago | $19.53 | $995.9 | -0.4% |
| 1 year ago | $15.4 | $1,262.99 | +26.3% |
| All time (5.0y) ago | $24.53 | $792.91 | -20.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our HQH forecast.
Our base-case forecast reaches $39.00 around 2031.
Implied market cap at $39.00: $2.23B
The year-by-year forecast shows a rising trajectory for the asset with a bullish bias from 2027 onward. In 2026 the average price is $19.47 with a neutral sentiment and 0% ROI. The outlook strengthens in later years, with 2027 averaging $26.68 (ROI 37%), 2028 $31.95 (ROI 64.1%), 2029 $34.55 (ROI 77.4%), 2030 $38.20 (ROI 96.2%), 2031 $39.34 (ROI 102%), 2032 $43.15 (ROI 121.6%), 2033 $50.96 (ROI 161.7%), 2034 $56.24 (ROI 188.9%), 2035 $64.68 (ROI 232.2%), 2040 $90.39 (ROI 364.3%), and 2050 $178.43 (ROI 816.4%).
The sentiment remains BULLISH across this horizon, though these figures are estimates, not guarantees, and actual results may vary.
Tap a question to reveal the answer.
Avg $38.20, min $29.79, max $52.19, ROI 96.2%, sentiment BULLISH.
Avg $90.39, min $64.12, max $138.03, ROI 364.3%, sentiment BULLISH.
Current price is $19.47. The 2026 forecast shows avg $19.47, min $17.25, max $25.89, ROI 0, sentiment NEUTRAL.
Yes. The 2050 forecast shows avg $178.43, which is above $100. The 2040 forecast is $90.39, so crossing above $100 is projected to occur between 2040 and 2050.
The forecast projects a bullish trajectory with rising averages: 2027 $26.68, 2028 $31.95, 2029 $34.55, 2030 $38.20, 2031 $39.34, 2032 $43.15, 2033 $50.96, 2034 $56.24, 2035 $64.68, 2040 $90.39, and 2050 $178.43, accompanied by increasing ROIs up to 816.4%. These are estimates, not guarantees.
Abrdn Healthcare Investors Community Discussion
0Share your Abrdn Healthcare Investors price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.